The Influence of Different Types of Physical Exercise on Immunosenescence in Elderly Persons

January 10, 2022 updated by: Prof. Ivan Bautmans, Vrije Universiteit Brussel

The Influence of Different Types of Physical Exercise on Immunosenescence in Elderly Persons - Senior Project Intensive Training (SPRINT)

This study aims to identify the mechanisms by which physical exercise can counter inflammation and improve immune function in older persons. These mechanisms will be investigated to develop exercise-based/derived strategies to improve recovery of older patients suffering from immunosenescence and/or immune suppression.

In this randomized controlled trial, the effects of resistance exercise (RE) on inflammation and chronic low-grade inflammation (CLIP) will be investigated.

The investigators expect that exercise-induced changes in immunosenescence will be reflected by changes in the various domains of interest: 1) the expression of immunosenescence-related genes in PMBC, in circulating markers of inflammation and in PMBC behaviour following LPS stimulation, 2) the proportion of circulating PMBC showing surface and/or intracellular markers for cell senescence, and 3) markers reflecting alterations at the level of the extracellular matrix.

Additionally, the investigators want to verify whether 1) resistance exercise improves inflammation and immunosenescence in skin tissue, and 2) resistance exercise improves the stress response in skin tissue after an in-vivo inflammatory challenge by saline injection.

The results of this project will allow us to provide new insights in the complex interaction between physical exercise and immunosenescence as well as to present evidence-based guidelines for exercise in elderly persons to counter CLIP

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Brussels
      • Jette, Brussels, Belgium, 1090
        • Recruiting
        • Vrije Universiteit Brussel
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged people (male or female) living independently in the community;
  • Aged ≥65yrs.

Exclusion Criteria:

  • Performing currently or within the past six months on a regular basis physical exercise at higher intensities than habitual daily activity (e.g. fitness classes, strengthening exercises, cycling club);
  • Presenting contra-indications for any of the exercise interventions;
  • Cognitive impairment (unable to understand or execute the test/exercise instructions due to cognitive impairment (MMSE<24/30));
  • Presenting physical disability;
  • Using anti-inflammatory and/or immunosuppressive medication
  • Presenting an acute inflammatory condition (CRP >10mg/L)

Exclusion Criteria for dermatology part:

  • use of medications that cannot be temporarily interrupted for this study:

    • medication that suppresses allergic reaction,
    • Anticoagulation,
    • Treatment with cortisone creams, calcineurin inhibitor creams (Elidel, Protopic) within 7 days before the first visit,
    • Treatment with the following medication within 5 half-lives for the first visit: systemic immunosuppressive / immunomodulating medications (e.g. methotrexate (Ledertrexat), cyclosporine (Neoral), azathioprine (Imuran), mycomofetil phenolate (Cellcept)), Cortisone tablets (eg Medrol) (except use of cortisone in the form of nasal spray, puffer, eye drops), Targeted biological treatment (monoclonal antibodies or inhibitors, eg Dupixent),
  • undergoing or have undergone allergen-specific immunotherapy,
  • participating in another interventional clinical study for atopic dermatitis,
  • showing inflammatory skin diseases (e.g. atopic eczema, psoriasis).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intensive strength training (IST)
Experimental: Strength Endurance training (SET)
Other: Flexibility training (FT)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peripheral blood of older adults will be investigated by qPCR to reveal changes in the inflammatory profile
Time Frame: Change from Baseline inflammatory profile at 6 weeks
The primary objective is to investigate the effects of strength training on inflammation- and immunosenescence-related genes in peripheral blood mononuclear cells
Change from Baseline inflammatory profile at 6 weeks
Peripheral blood of older adults will be investigated by qPCR to reveal changes in the inflammatory profile
Time Frame: Change from Baseline inflammatory profile at 3 months
The primary objective is to investigate the effects of strength training on inflammation- and immunosenescence-related genes in peripheral blood mononuclear cells
Change from Baseline inflammatory profile at 3 months
Peripheral blood of older adults will be investigated by qPCR to reveal changes in the inflammatory profile
Time Frame: Change from Baseline inflammatory profile at 6 months
The primary objective is to investigate the effects of strength training on inflammation- and immunosenescence-related genes in peripheral blood mononuclear cells
Change from Baseline inflammatory profile at 6 months
Peripheral blood of older adults will be investigated by qPCR to reveal changes in the inflammatory profile
Time Frame: Change from Baseline inflammatory profile at 9 months
The primary objective is to investigate the effects of strength training on inflammation- and immunosenescence-related genes in peripheral blood mononuclear cells
Change from Baseline inflammatory profile at 9 months
Peripheral blood of older adults will be investigated by qPCR to reveal changes in the inflammatory profile
Time Frame: Change from Baseline inflammatory profile at 12 months
The primary objective is to investigate the effects of strength training on inflammation- and immunosenescence-related genes in peripheral blood mononuclear cells
Change from Baseline inflammatory profile at 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2011

Primary Completion (Anticipated)

December 1, 2023

Study Completion (Anticipated)

December 1, 2024

Study Registration Dates

First Submitted

July 3, 2020

First Submitted That Met QC Criteria

August 26, 2020

First Posted (Actual)

September 1, 2020

Study Record Updates

Last Update Posted (Actual)

January 26, 2022

Last Update Submitted That Met QC Criteria

January 10, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • FRIA_SPRINT_1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Aged Volunteers

Clinical Trials on Intensive Strength Training (IST)

3
Subscribe